Crystalline polymorph forms of 2-(5-bromo-4-(4-cyclopropyl naphthalen-1-yl)-4H-1,2,4-triazol-3-ylthio)acetic acid are described. Pharmaceutical compositions and the uses of such compounds, compound forms, and compositions for the treatment of a variety of diseases and conditions are also presented.本發明闡述2-(5-溴-4-(4-環丙基萘-1-基)-4H-1,2,4-三唑-3-基硫基)乙酸之結晶多晶型。本發明亦提供醫藥組合物及該等化合物、化合物形式及組合物用於治療多種疾病及病狀之用途。(無元件符號說明)